Karyopharm Therapeutics Inc (KPTI)
0.6447
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
0.6447
0.00 (0.00%)
After-Hours: 16:06
Karyopharm Therapeutics Profit Margin (Quarterly): -82.70% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 4.73% |
| Ionis Pharmaceuticals Inc | -105.0% |
| Apellis Pharmaceuticals Inc | -29.19% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -39.11% |
| Return on Invested Capital | -221.9% |
| Gross Profit Margin (Quarterly) | 96.65% |
| Operating Margin (Quarterly) | -67.77% |
| Return on Net Operating Assets | -213.9% |